retatrutide sequence (RETA) is one of the most promising investigational peptides in obesity research—but one important question deserves more attention: Can it affect birth control? Current evidence shows that GLP-1 receptor agonists slow Retatrutide (LY3437943) | GCGR/GIPR/GLP-1R Agonist
Description
It remains an investigational compound in Phase 3 clinical development
The influences of juvenile diabetes on memory and hippocampal plasticity in rats: Improving effects of glucagon-like peptide-1
During the first week on semaglutide GLP-1 , most people notice changes in appetite before anything else
Likewise, differences in the effect of regulatory peptides on AMPK as a function of nutritional status have been previously described
